$LEXG LEXICON PHARMACEUTICALS, INC. Insider Trading Week 16/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. in week 16/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 1.96 | 9,651 | 18,916 | 115,495 | 125.1 K to 115.5 K (-7.71 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Grant | A | 0.00 | 26,525 | 0 | 125,146 | 98.6 K to 125.1 K (+26.90 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 1.96 | 4,844 | 9,494 | 69,344 | 74.2 K to 69.3 K (-6.53 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Grant | A | 0.00 | 19,893 | 0 | 74,188 | 54.3 K to 74.2 K (+36.64 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.96 | 3,997 | 7,834 | 65,127 | 69.1 K to 65.1 K (-5.78 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Grant | A | 0.00 | 13,262 | 0 | 69,124 | 55.9 K to 69.1 K (+23.74 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 1.96 | 6,813 | 13,353 | 55,584 | 62.4 K to 55.6 K (-10.92 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Grant | A | 0.00 | 19,893 | 0 | 62,397 | 42.5 K to 62.4 K (+46.80 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Payment of Exercise | F | 1.96 | 6,813 | 13,353 | 104,640 | 111.5 K to 104.6 K (-6.11 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Grant | A | 0.00 | 19,893 | 0 | 111,453 | 91.6 K to 111.5 K (+21.73 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Payment of Exercise | F | 1.96 | 6,398 | 12,540 | 49,732 | 56.1 K to 49.7 K (-11.40 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Grant | A | 0.00 | 19,893 | 0 | 56,130 | 36.2 K to 56.1 K (+54.90 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 1.96 | 6,813 | 13,353 | 85,719 | 92.5 K to 85.7 K (-7.36 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Grant | A | 0.00 | 19,893 | 0 | 92,532 | 72.6 K to 92.5 K (+27.39 %) |